Trial · NCT01147744
Results by group84
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 84
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline to the End of the 8-Week Treatment Period in Trough Forced Expiratory Volume in One Second (FEV1) | Placebo | 0.12 | Standard Error 0.04 | Liters | |
| Mean Change From Baseline to the End of the 8-Week Treatment Period in Trough Forced Expiratory Volume in One Second (FEV1) | GSK2190915 10 mg | 0.18 | Standard Error 0.04 | Liters | |
| Mean Change From Baseline to the End of the 8-Week Treatment Period in Trough Forced Expiratory Volume in One Second (FEV1) | GSK2190915 30 mg | 0.23 | Standard Error 0.04 | Liters | |
| Mean Change From Baseline to the End of the 8-Week Treatment Period in Trough Forced Expiratory Volume in One Second (FEV1) | GSK2190915 100 mg | 0.19 | Standard Error 0.04 | Liters | |
| Mean Change From Baseline to the End of the 8-Week Treatment Period in Trough Forced Expiratory Volume in One Second (FEV1) | GSK2190915 300 mg | 0.19 | Standard Error 0.04 | Liters | |
| Mean Change From Baseline to the End of the 8-Week Treatment Period in Trough Forced Expiratory Volume in One Second (FEV1) | Fluticasone Propionate 100 mcg | 0.31 | Standard Error 0.04 | Liters | |
| Mean Change From Baseline to the End of the 8-Week Treatment Period in Trough Forced Expiratory Volume in One Second (FEV1) | Montelukast 10 mg | 0.19 | Standard Error 0.04 | Liters | |
| Mean Change From Baseline in Daily Evening (PM) Peak Expiratory Flow (PEF) Averaged Over the 8-Week Treatment Period | Placebo | 8.01 | Standard Error 3.19 | Liters per minute | |
| Mean Change From Baseline in Daily Evening (PM) Peak Expiratory Flow (PEF) Averaged Over the 8-Week Treatment Period | GSK2190915 10 mg | 7.62 | Standard Error 3.19 | Liters per minute | |
| Mean Change From Baseline in Daily Evening (PM) Peak Expiratory Flow (PEF) Averaged Over the 8-Week Treatment Period | GSK2190915 30 mg | 9.37 | Standard Error 3.20 | Liters per minute | |
| Mean Change From Baseline in Daily Evening (PM) Peak Expiratory Flow (PEF) Averaged Over the 8-Week Treatment Period | GSK2190915 100 mg | 6.21 | Standard Error 3.17 | Liters per minute | |
| Mean Change From Baseline in Daily Evening (PM) Peak Expiratory Flow (PEF) Averaged Over the 8-Week Treatment Period | GSK2190915 300 mg | 10.33 | Standard Error 3.15 | Liters per minute | |
| Mean Change From Baseline in Daily Evening (PM) Peak Expiratory Flow (PEF) Averaged Over the 8-Week Treatment Period | Fluticasone Propionate 100 mcg | 10.46 | Standard Error 3.16 | Liters per minute | |
| Mean Change From Baseline in Daily Evening (PM) Peak Expiratory Flow (PEF) Averaged Over the 8-Week Treatment Period | Montelukast 10 mg | 8.53 | Standard Error 3.24 | Liters per minute | |
| Mean Change From Baseline in Daily Trough AM PEF Averaged Over the 8-Week Treatment Period | Placebo | 11.77 | Standard Error 3.28 | Liters per minute | |
| Mean Change From Baseline in Daily Trough AM PEF Averaged Over the 8-Week Treatment Period | GSK2190915 10 mg | 13.23 | Standard Error 3.28 | Liters per minute | |
| Mean Change From Baseline in Daily Trough AM PEF Averaged Over the 8-Week Treatment Period | GSK2190915 30 mg | 15.52 | Standard Error 3.29 | Liters per minute | |
| Mean Change From Baseline in Daily Trough AM PEF Averaged Over the 8-Week Treatment Period | GSK2190915 100 mg | 8.72 | Standard Error 3.26 | Liters per minute | |
| Mean Change From Baseline in Daily Trough AM PEF Averaged Over the 8-Week Treatment Period | GSK2190915 300 mg | 16.35 | Standard Error 3.24 | Liters per minute | |
| Mean Change From Baseline in Daily Trough AM PEF Averaged Over the 8-Week Treatment Period | Fluticasone Propionate 100 mcg | 15.25 | Standard Error 3.26 | Liters per minute |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01147744/results